Millennium Management
AMAM

Millennium Management’s Ambrx Biopharma Inc AMAM Stock Holding History

Millennium Management’s Portfolio AMAM Stock Details AMAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-432,709
Closed -$6.16M – 6831
2023
Q4 		$6.16M Sell
432,709
-31,924
-7% -$363K ﹤0.01% 2612
2023
Q3 		$5.34M Buy
464,633
+178,917
+63% +$2.44M ﹤0.01% 2621
2023
Q2 		$4.7M Buy
285,716
+274,727
+2,500% +$3.45M ﹤0.01% 2733
2023
Q1 		$98K Sell
10,989
-7,804
-42% -$39.2K ﹤0.01% 5436
2022
Q4 		$43K Sell
18,793
-94,899
-83% -$108K ﹤0.01% 5830
2022
Q3 		$123K Buy
113,692
+10,916
+11% +$22.5K ﹤0.01% 5896
2022
Q2 		$272K Sell
102,776
-1,653
-2% -$6.3K ﹤0.01% 5449
2022
Q1 		$430K Buy
104,429
+6,010
+6% +$30.7K ﹤0.01% 5238
2021
Q4 		$889K Sell
98,419
-43,012
-30% -$480K ﹤0.01% 4516
2021
Q3 		$1.91M Sell
141,431
-2,661
-2% -$47.9K ﹤0.01% 3988
2021
Q2 		$2.82M Buy
+144,092
New +$2.46M ﹤0.01% 3514

Millennium Management's AMAM Position: Q1 2024 in Review

Millennium Management sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 432,709 shares — an estimated $6.16M sold.

Millennium Management first reported a position in AMAM in Q2 2021 and held it in 11 quarters. The position peaked at $6.16M in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

  • Millennium Management reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
  • Millennium Management sold 432,709 Ambrx Biopharma Inc shares in Q1 2024, an estimated $6.16M.
  • Millennium Management first reported a position in Ambrx Biopharma Inc in Q2 2021 and held it in 11 quarters.
  • Millennium Management's Ambrx Biopharma Inc position peaked at $6.16M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.